Skip to content
Search

Latest Stories

Pharmacists expand roles for better patient outcomes through self-care: report

Pharmacists expand roles for better patient outcomes through self-care: report

The report highlighted key themes to improve community pharmacy for enhanced self-care support

Pharmacists globally are broadening their roles to support self-care, aiming to enhance patient health outcomes through increased contributions and proactive behaviours, according to a new report.


However, significant barriers, including inadequate funding and limited access to patient records, impede the optimisation of self-care activities and outcomes improvement in this area, the International Pharmaceutical Federation (FIP) said in its report.

The FIP report, titled 'Community Pharmacy Insights: Supporting the Need for Self-Care,' gathers insights from 238 respondents across 55 countries with the aim of providing evidence-based policy support for workforce development.

Nearly all respondents (93.2 per cent) indicated that pharmacists should actively engage in providing self-care support, FIP said. Furthermore, 48.9 per cent supported the involvement of pharmacy technicians, while 39.2 per cent endorsed the participation of pharmacy assistants and other team members in offering self-care support.

Educating and advising patients on their self-limiting conditions emerged as the most commonly reported approach by respondents (79.4 per cent), followed by guidance on the use of medication for self-limiting conditions (74.4 per cent) and providing medicines to patients (59.2 per cent).

According to FIP, the majority of respondents supported self-care statements related to actively assisting patients in healthcare decisions and consultations (87 per cent), medication adherence (89.9 per cent), and facilitating lifestyle changes (85.7 per cent).

Meanwhile, health education websites are the most widely used resources by respondents to support self-care (44.5 per cent), followed by health tracking apps (36.6 per cent) and diagnostic tests (29.8 per cent).

"The primary healthcare context is evolving rapidly, driven by an increasing emphasis on self-care where appropriate," said Ian Bates, Director of the FIP Global Pharmaceutical Observatory. "Empowering patients with self-care is a significant way in which pharmacists can support universal health coverage, and, as evident throughout this report, community pharmacists recognise the importance of being able to offer effective support activities."

The report also identified key themes for enhancing community pharmacy practice and overall management for more effective self-care support delivery, emphasizing the utilisation of digital self-care tools and healthcare technologies.

"Educating and training pharmacists to support self-care remains a necessity to bring tangible benefits to patients," Bates added. "This can enhance patients’ health literacy and awareness, assisting them in better self-care, thereby contributing to economic impacts and maintaining sustainable and efficient services."

In October, FIP launched a report on pharmacy-led common ailment schemes, emphasising improved access to care, enhanced patient quality of life, and cost-effective alternatives, all contributing to the reduction of GP workloads.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less